Diagnostic Accuracy of a CA125-Based Biomarker Panel in Patients with Pancreatic Cancer: A Systematic Review and Meta-Analysis
Qingcai Meng, Si Shi, Chen Liang, Jinfeng Xiang, Dingkong Liang, Bo Zhang, Yi Qin, Shunrong Ji, Wenyan Xu, Jin Xu, Quanxing Ni, Xianjun Yu · Journal of Cancer · 2017
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Journal of Cancer · Ivyspring International Publisher · review · 2017
Abstract
Background: Increasing evidence from recent studies has revealed the association of CA125 with the diagnosis of pancreatic cancer, but inconsistent findings have been reported.We aimed to evaluate the diagnostic value of a serum CA125-based diagnostic panel in predicting malignant pancreatic cancer.Materials and Methods: We searched EMBASE, MEDLINE and Web of Science for relevant articles from inception to October 2016.Methodological quality was evaluated using the Quality Assessment of Comparative Diagnostic Accuracy Studies (QUADAS-2) checklist.The performance characteristics were pooled using random-effects models.The statistical analysis was performed using Meta-Disc 1.4 and Stata Version 12.0 software.Results: A total of 1235 participants pooled from 8 eligible studies were included in the meta-analysis to evaluate the accuracy of tumor predictors for the diagnosis of pancreatic cancer.The pooling accuracy analysis of CA125 alone indicated that the pooled sensitivity was 0.59 (95% CI: 0.54-0.62)and the specificity was 0.78 (95% CI: 0.75-0.82),whereas the serum CA125-based diagnostic panel had a pooled sensitivity of 0.47 (95% CI 0.47-0.51)and a specificity of 0.88 (95% CI 0.86-0.90).Furthermore, the AUC and Q-value of the CA125-based diagnostic panel were 0.89 and 0.82, respectively, which indicated that the CA125-based panel is superior to CA125 or CA19-9 alone in diagnosing pancreatic cancer.No obvious publication bias was found.Conclusions: In summary, a CA125-based diagnostic panel is better at diagnosing pancreatic cancer than a test using CA125 or CA19-9 alone.Further studies should be performed to confirm our conclusion.
Open the resolved locator · 10.7150/jca.18901
Metadata licence: OpenAlex metadata (CC0)